Jason Kirk

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer”.

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer

Cancer Chemotherapy and Pharmacology(2025)10.1007/s00280-025-04840-2

N/A

0.241DataRank · unranked

4 citations

Anmbreen Jamroze, Dharmesh Gopalakrishnan, Rohit Jain, Changchuan Jiang, Julianne L. Holleran +11 more

Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer

Nature Communications(2020)10.1038/s41467-020-15815-7

N/A

0DataRank · unranked

137 citations

Qiang Hu, Xiaozhuo Liu, Yibing Ji, Hsueh‐Ping Chao, Yan Liu +8 more

A phase Ib trial of enzalutamide with venetoclax in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps5599

N/A

0DataRank · unranked

2 citations

Jason Kirk, John W. Davis, Saby George, Ellis Levine, Jan H. Beumer +4 more

Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer

Cell Reports(2021)10.1016/j.celrep.2021.110109

N/A

0DataRank · unranked

34 citations

Justine J. Jacobi, Prashant K. Singh, Gerard Llimos, Sajad A. Wani, Aryn M. Rowsam +10 more

Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells

Cell stem cell(2024)10.1016/j.stem.2024.05.008

N/A

0DataRank · unranked

20 citations

Jie Wang, Mark D. Long, Spencer R. Rosario, Amanda Tracz, Yibing Ji +16 more

Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer

medRxiv(2025)10.1101/2025.04.22.25326208

N/A

0DataRank · unranked

1 citations

Anmbreen Jamroze, Dharmesh Gopalakrishnan, Rohit Jain, Changchuan Jiang, Julianne L. Holleran +10 more